P2.09-07 Safety and Efficacy of Aumolertinib in Patients with advanced NSCLC Harboring Uncommon EGFR Mutations: Cohort 2 UpdatedW.F. Fang, Q. Bu,Q.M. Wang, W.H. Zhao,L.P. Wang, X.R. Dong, P.F. Chen, Z.B. Wen, J. Jia, G.M. Jiang, L. ZhangJournal of Thoracic Oncology（2023）引用 0|浏览0暂无评分关键词egfr mutations,aumolertinibAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
